Taking a Bite Out of Vector-Transmitted Infectious Diseases
- 21 June 2007
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 356 (25) , 2567-2569
- https://doi.org/10.1056/nejmp078081
Abstract
It is hard to overstate the medical importance and burden of vector-transmitted infectious diseases. Whether the metric used is mortality (malaria, for example, kills 1 million to 2 million people annually, most of them children under 5 years of age), morbidity (more than 70 million years of healthy living are lost to malaria, Chagas' disease, leishmaniasis, dengue fever, lymphatic filariasis, and the encephalitis viruses), or something as difficult to quantify as anxiety in a population (activities in outdoor playgrounds and high schools, for example, were moved or suspended along the south shore of Massachusetts this past fall because of concern raised by three cases of eastern equine encephalitis), the burden of these infections is enormous.Keywords
This publication has 6 references indexed in Scilit:
- Injectable Paromomycin for Visceral Leishmaniasis in IndiaNew England Journal of Medicine, 2007
- Transgenic malaria-resistant mosquitoes have a fitness advantage when feeding onPlasmodium-infected bloodProceedings of the National Academy of Sciences, 2007
- An Antivector Vaccine Protects against a Lethal Vector-Borne PathogenPLoS Pathogens, 2006
- An ecological approach to preventing human infection: Vaccinating wild mouse reservoirs intervenes in the Lyme disease cycleProceedings of the National Academy of Sciences, 2004
- Toward a Defined Anti-Leishmania Vaccine Targeting Vector AntigensThe Journal of Experimental Medicine, 2001
- Prognosis for Interruption of Malaria Transmission Through Assessment of the Mosquito's Vectorial CapacityNature, 1964